Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N2NI
|
||||
| Drug Name |
Entrectinib
|
||||
| Indication | Mammary analogue secretory carcinoma [ICD10:C07] | Phase 1 | [1] | ||
| Colorectal cancer [ICD10:C18-C21] | Phase 1 | [1] | |||
| Structure |
|
Download2D MOL |
|||
| Drug Resistance Mutation (DRM) | |||||
| DRM | DRM Info | ||||
| References | |||||
| REF 1 | Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.